[Comment on the contribution by U. Beiteke et al. Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. First comment].
作者信息
Windeler J, Lange S, Trampisch H J
机构信息
Abt. Medizinische Biometrie, Ruprecht-Karls-Universität, Heidelberg.
出版信息
Hautarzt. 1994 Mar;45(3):189-90; author reply 193-4.
PMID:8175351
Abstract
摘要
相似文献
1
[Comment on the contribution by U. Beiteke et al. Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. First comment].
Hautarzt. 1994 Mar;45(3):189-90; author reply 193-4.
2
[Comment on the contribution by U. Beiteke et al. Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. Second comment].
Hautarzt. 1994 Mar;45(3):191-2; author reply 193-4.
3
4
Adjuvant interferon-alpha in malignant melanoma: current status.
Cancer Treat Rev. 2000 Apr;26(2):81-9. doi: 10.1053/ctrv.1999.0163.
5
[Interferon therapy in malignant melanoma].
Wien Med Wochenschr. 1993;143(16-17):441-2.
6
Multidisciplinary treatment of primary melanoma.
Surg Clin North Am. 2009 Feb;89(1):267-81, xi. doi: 10.1016/j.suc.2008.11.002.
7
8
9
[Diagnosis, treatment and follow-up of primary malignant skin melanoma].
Rev Med Suisse Romande. 1995 Oct;115(10):753-7.
10
[Therapeutic manual of malignant melanoma].
Fukuoka Igaku Zasshi. 2009 Feb;100(2):51-8.
Zotero 插件